[Amiodarone in the control of supraventricular tachyarrhythmias].

Abstract

The clinical efficacy of amiodarone was observed in a group of 20 patients (9 women and 11 men) with a total 21 supraventricular tachyarrhythmias (16 paroxysms or premature supraventricular beats (PSB) and 5 with established arrhythmias), to whom amiodarone was given during one month: 800 mg/day the first week and 400 mg/day for 3 weeks. An electrocardiogram and a 24 hour Holter were taken before and after treatment. The results observed for paroxysmal arrhytmias and PSB were excellent in 94% and satisfactory in one patient. As for established arrhythmias the results were excellent or satisfactory in 80%. We conclude that ammiodarone is an effective drug with a wide security range in the treatment of supraventricular arrhythmias.

• Authors: L Molina, P Heredia, R Pinto, A Mesa, A Villarreal, E Gutiérrez Fuster
• Journal: Archivos del Instituto de Cardiologia de Mexico (Arch Inst Cardiol Mex) 1983 Jan-Feb Vol. 53 Issue 1 Pg. 13-6 ISSN: 0020-3785 [Print] Mexico
• Vernacular Title: La amiodarona en el control de las taquiarritmias supraventriculares.
• PMID: 6191726 (Publication Type: English Abstract, Journal Article)

Chemical References

• Benzofurans
• Amiodarone

Topics

• Adolescent
• Adult
• Aged
• Amiodarone (administration & dosage, therapeutic use)
• Arrhythmias, Cardiac (drug therapy)
• Benzofurans (therapeutic use)
• Cardiac Complexes, Premature (drug therapy)
• Child
• Drug Evaluation
• Electrocardiography
• Exercise Test
• Female
• Humans
• Male
• Middle Aged
• Tachycardia, Paroxysmal (drug therapy)